New Drug for Treatment of Parkinson’s Disease Introduced in India

The drug Apomorphine has been launched in India for the first time to treat Parkinson patients. 

1 min read

A private hospital in Bengaluru, has launched Apomorphine for the first time in India, in association with Britannia Pharmaceuticals, a UK-based pharmaceutical company.

The drug has helped in the treatment of Parkinson’s in other countries and now, there is hope for Indians suffering from the disease.

It is available as both injections and infusion pumps, and can provide relief within minutes.


As reported in The New Indian Express, Dr Prashant LK, Parkinson’s Disease and Movement Disorders Specialist at Vikram Hospital, explained that currently in India, patients of Parkinson’s have only two options: either oral treatment for the early stages of the disease, or very expensive Deep Brain Stimulation (DBS) surgery for advanced stages.

There was no treatment for the middle stages of the disease. Moreover, most patients in India couldn’t afford DBS.

Introduction of apomorphine in India has given an important medical option to doctors in the middle stages of the management of Parkinson’s Disease.
Dr Prashant LK

The drug will distributed in the country by Vikram Hospitals and then made available in selected centres across the country after the approval of the Drug Controller General of India

Parkinson’s is a neurological disorder that is mainly characterized by problems with body movements, although other symptoms may also occur.

It is estimated that about 30 million people in India suffer from various forms of neurological diseases.

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

Speaking truth to power requires allies like you.
Become a Member
Read More